New Key Statistics Module, Z-Score and F-Score
SZSE:002750 Key Ratios
Market Cap ¥ M | 929.16 |
Enterprise Value ¥ M | 675.03 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.84 |
Price/Sales | 14.97 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 62.00 |
EPS (TTM) ¥ | -0.13 |
Beneish M-Score | -3.08 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -18.14 |
EV-to-EBITDA | -18.14 |
PEG | -- |
Shares Outstanding M | 400.50 |
Net Margin (%) | -86.26 |
Operating Margin % | -67.90 |
Pre-tax Margin (%) | -100.81 |
Quick Ratio | 7.69 |
Current Ratio | 8.44 |
ROA % (ttm) | -8.47 |
ROE % (ttm) | -10.37 |
ROIC % (ttm) | -16.66 |
Dividend Yield % | -- |
Altman Z-Score | 9.04 |
SZSE:002750 Number of Guru Trades
SZSE:002750 Volume of Guru Trades
Gurus Latest Trades with SZSE:002750
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002750 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kunming Longjin Pharmaceutical Co Ltd Insider Transactions
No Available Data